Brief rerport
Efficacy evaluaton of a 4% chlorhexidine gluconate as a full-body shower wash

https://doi.org/10.1016/0196-6553(93)90033-ZGet rights and content

Abstract

A 4% chlorhexidine gluconate (Xttrium Laboratories, Chicago, Ill.) was used in a shower bath application to evaluate its merits in reducing resident skin microorganisms. Five volunteers completed a 14-day microbial stabilization period, a 7-day baseline period, and a 5-day test period. Subjects followed a standard protocol, performed five shower washes and were sampled at both the abdominal and inguinal regions immediately after the shower wash as well as at 3 and 6 hours later on days 1, 2, and 5. Chlorhexidine gluconate provided significant microbial reductions from baseline, with greater reductions noted as the study progressed. Use of chlorhexidine gluconate in a shower wash application in conjunction with a preoperative skin-preparation procedure may reduce the probability of surgically associated infections.

References (9)

There are more references available in the full text version of this article.

Cited by (67)

  • Contemporary Review to Reduce Groin Surgical Site Infections in Vascular Surgery

    2021, Annals of Vascular Surgery
    Citation Excerpt :

    In a study of more than 700 patients who received two preoperative antiseptic showers, chlorhexidine caused a nine-fold decrease in skin bacterial colony counts, while povidone-iodine and medicated soap reduced the colony counts by 1.3-fold and 1.9-fold, respectively.29 Similar studies conducted by Hayek et al., Paulson et al., and May et al. corroborate these findings.30–32 Moreover, Edmiston et al. demonstrated that using a standardized preadmission shower regimen that included at least two showers using 4% chlorhexidine, and a 1-minute pause before rinsing, achieved maximal skin surface concentration of chlorhexidine; these concentrations were adequate to inhibit or kill both gram-positive and gram-negative surgical wound pathogens present on the skin preoperatively.33

  • Prevention of Perioperative Surgical Site Infection

    2021, Perioperative Medicine: Managing for Outcome, Second Edition
  • A Randomized, Clinical Trial of Preadmission Chlorhexidine Skin Preparation for Lower Extremity Total Joint Arthroplasty

    2016, Journal of Arthroplasty
    Citation Excerpt :

    This superiority is attributed to rapid bactericidal action and long-lasting residual effects on the skin [20]. It inactivates microorganisms on the skin surface and prevents microbial recolonization in the presence of body fluids [10,29]. In Springer and Parvizi's book, Potter et al [24] evaluated the use of chlorhexidine and intranasal mupirocin decolonization protocol for Staphylococcus aureus and reported up to an 81% reduction in surgical site infections in those using this protocol [30-34].

  • Prevention of Operative Infections: An Evidence-Based Approach

    2016, Benzel's Spine Surgery: Techniques, Complication Avoidance and Management: Volume 1-2, Fourth Edition
  • Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers

    2015, Clinical Microbiology and Infection
    Citation Excerpt :

    Thus, eradication of S. aureus nasal carriage may prevent nosocomial infections, and such interventions have been proven to be clinically effective [8,14–17]. For instance, mupirocin treatment combined with chlorhexidine washings was effective in eliminating S. aureus from both the nares and skin [18,19], which reduced the number of nosocomial S. aureus endo-infections. Whether prior nasal colonization with a methicillin-susceptible S. aureus (MSSA) strain protects against acquisition of exogeneous MSSA or methicillin-resistant S. aureus (MRSA) is still largely unknown [20,21].

View all citing articles on Scopus
View full text